Age- And sex-specific causal effects of adiposity on cardiovascular risk factors

Diabetes

Volumn 64, Issue 5, 2015, Pages 1841-1852

  Fall, Tove ^a   Hägg, Sara ^a,b   Ploner, Alexander ^b   Mägi, Reedik ^c   Fischer, Krista ^c   Draisma, Harmen H M ^d,e   Sarin, Antti Pekka ^f,g   Benyamin, Beben ^h,i   Ladenvall, Claes ^j   Åkerlund, Mikael ^j   Kals, Mart ^c,k   Esko, Tõnu ^c,l,m,n   Nelson, Christopher P ^o,p   Kaakinen, Marika ^q   Huikari, Ville ^q   Mangino, Massimo ^r   Meirhaeghe, Aline ^s   Kristiansson, Kati ^g   Nuotio, Marja Liisa ^g   Kobl, Michael ^t   Grallert, Harald ^t,u   Dehghan, Abbas ^v   Kuningas, Maris ^v,w   De Vries, Paul S ^v   De Bruijn, Renée F A G ^v   Willems, Sara M ^v   Heikkilä, Kauko ^f   Silventoinen, Karri ^f   Pietiläinen, Kirsi H ^f,x   Legry, Vanessa ^s   Giedraitis, Vilmantas ^y   Goumidi, Louisa ^s   Syvänen, Ann Christine ^a   Strauch, Konstantin ^t,z   Koenig, Wolfgang ^aa   Lichtner, Peter ^t   Herder, Christian ^u,ab   Palotie, Aarno ^f,g,n   Menni, Cristina ^r   Uitterlinden, André G ^v   Kuulasmaa, Kari ^g   Havulinna, Aki S ^g   Moreno, Luis A ^ac   Gonzalez Gross, Marcela ^ad   Evans, Alun ^ae   Tregouet, David Alexandre ^af,ag,ah   Yarnell, John W G ^ae   Virtamo, Jarmo ^g   Ferrières, Jean ^ai   Veronesi, Giovanni ^aj   Perola, Markus ^g   Arveiler, Dominique ^ak   Brambilla, Paolo ^al   Lind, Lars ^a   Kaprio, Jaakko ^f,g   Hofman, Albert ^v   Stricker, Bruno H ^v,w   Van Duijn, Cornelia M ^v   Ikram, M Arfan ^v   Franco, Oscar H ^v   Cottel, Dominique ^s   Dallongeville, Jean ^s   Hall, Alistair S ^am   Jula, Antti ^g   Tobin, Martin D ^p   Penninx, Brenda W ^e,an   Peters, Annette ^t   Gieger, Christian ^t   Samani, Nilesh J ^o,p   Montgomery, Grant W ⁱ   Whitfield, John B ⁱ   Martin, Nicholas G ⁱ   Groop, Leif ^f,j   Spector, Tim D ^r   Magnusson, Patrik K ^b   Amouyel, Philippe ^s   Boomsma, Dorret I ^d,e   Nilsson, Peter M ^ao   Järvelin, Marjo Riitta ^g,q,ap,aq   Lyssenko, Valeriya ^j,ar   Metspalu, Andres ^c   Strachan, David P ^as   Salomaa, Veikko ^g   Ripatti, Samuli ^f,g,at   Pedersen, Nancy L ^b   Prokopenko, Inga ^at,au,av   Mccarthy, Mark I ^at,av,aw   Ingelsson, Erik ^a,at   more..

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF TARTU   (Estonia)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY OF HELSINKI   (Finland)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h UNIVERSITY OF QUEENSLAND   (Australia)

ⁱ QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

^k UNIVERSITY OF TARTU   (Estonia)

^l BOSTON CHILDREN S HOSPITAL   (United States)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^o GLENFIELD HOSPITAL   (United Kingdom)

^p UNIVERSITY OF LEICESTER   (United Kingdom)

^q UNIVERSITY OF OULU   (Finland)

^r KING'S COLLEGE LONDON   (United Kingdom)

^s UNIV LILLE   (France)

^t INSTITUTE OF EPIDEMIOLOGY   (Germany)

^u GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^v ERASMUS MEDICAL CENTER   (Netherlands)

^w Helsinki University Central Hospital ^*  (Netherlands)

^x HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^y UPPSALA UNIVERSITY   (Sweden)

^z UNIVERSITY OF MUNICH   (Germany)

^aa UNIVERSITY HOSPITAL ULM   (Germany)

^ab HEINRICH HEINE UNIVERSITY   (Germany)

^ac UNIVERSITY OF ZARAGOZA   (Spain)

^ad UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^ae QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^af SORBONNE UNIVERSITÉ   (France)

^ag Sorbonne Universités   (France)

^ah Institute of Cardiometabolism and Nutrition (ICAN)   (France)

^ai UNIVERSITÉ PAUL SABATIER   (France)

^aj UNIVERSITY OF INSUBRIA   (Italy)

^ak UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^al UNIVERSITY OF MILANO BICOCCA   (Italy)

^am UNIVERSITY OF LEEDS   (United Kingdom)

^an VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^ao LUND UNIVERSITY   (Sweden)

^ap Faculty of Medicine and MRC Health Protection Agency   (United Kingdom)

^aq OULU UNIVERSITY HOSPITAL   (Finland)

^ar STENO DIABETES CENTER   (Denmark)

^as ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^at UNIVERSITY OF OXFORD   (United Kingdom)

^au IMPERIAL COLLEGE LONDON   (United Kingdom)

^av UNIVERSITY OF OXFORD   (United Kingdom)

^aw CHURCHILL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; INSULIN;

ADULT; AGING; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC MARKER; GENETIC VARIATION; GENOTYPE; GLUCOSE HOMEOSTASIS; GLYCEMIC INDEX; HUMAN; HYPERTENSION; INFLAMMATION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; OBESITY; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADIPOSITY; AGING; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; HUMANS; INSULIN; INTERLEUKIN-6; MALE; MIDDLE AGED; SEX FACTORS; TRIGLYCERIDES;

EID: 84964694797     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0988     Document Type: Article

References (41)

1. Gersh BJ, Sliwa K, Mayosi BM, Yusuf S. Novel therapeutic concepts: The epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 2010;31:642-648.
2. Wenger NK. Gender disparity in cardiovascular disease: bias or biology? Expert Rev Cardiovasc Ther 2012;10:1401-1411.
3. Anand SS, Islam S, Rosengren A, et al.; INTERHEART Investigators. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008;29:932-940.
4. Dow CA, Thomson CA, Flatt SW, Sherwood NE, Pakiz B, Rock CL. Predictors of improvement in cardiometabolic risk factors with weight loss in women. J Am Heart Assoc 2013;2:e000152.
5. Siebenhofer A, Jeitler K, Berghold A, et al. Long- Term effects of weightreducing diets in hypertensive patients. Cochrane Database Syst Rev 2011;CD008274.
6. Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol 2014;2:152-164.
7. Fall T, Hägg S, Mägi R, et al.; European Network for Genetic and Genomic Epidemiology (ENGAGE) consortium. The role of adiposity in cardiometabolic traits: A Mendelian randomization analysis. PLoS Med 2013;10:e1001474.
8. Nordestgaard BG, Palmer TM, Benn M, et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med 2012;9:e1001212.
9. Sheehan NA, Didelez V, Burton PR, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med 2008;5:e177.
10. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583-1587.
11. Tchernof A, Després JP. Pathophysiology of human visceral obesity: An update. Physiol Rev 2013;93:359-404.
12. Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med 2009;6(Suppl. 1):60-75.
13. Pikilidou MI, Scuteri A, Morrell C, Lakatta EG. The burden of obesity on blood pressure is reduced in older persons: The SardiNIA study. Obesity (Silver Spring) 2013;21:E10-E13.
14. Whitlock G, Lewington S, Sherliker P, et al.; Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009;373:1083-1096.
15. Chen Y, Rennie DC, Reeder BA. Age-related association between body mass index and blood pressure: The Humboldt Study. Int J Obes Relat Metab Disord 1995;19:825-831.
16. Wakabayashi I. Relationships of body mass index with blood pressure and serum cholesterol concentrations at different ages. Aging Clin Exp Res 2004;16:461-466.
17. Wakabayashi I, Daimon T. Age-dependent decline of association between obesity and hyperglycemia in men and women. Diabetes Care 2012;35:175-177.
18. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010;363:2211-2219.
19. Speliotes EK, Willer CJ, Berndt SI, et al.; MAGIC; Procardis Consortium. Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010;42:937-948.
20. de Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, Voight BF. Practical aspects of imputation-driven meta- Analysis of genome-wide association studies. Hum Mol Genet 2008;17:R122-R128.
21. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org, 2013.
22. Lumley T. rmeta: Meta- Analysis. R package version 2.16. http://CRAN.R-project.org/package=rmeta, 2012.
23. Palmer TM, Sterne JA, Harbord RM, et al. Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am J Epidemiol 2011;173:1392-1403.
24. Benjamini Y, Hochberg Y. Controlling the false discovery rate- A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995;57:289-300.
25. Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm 2013;2013:139239.
26. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011;11:85-97.
27. Gao H, Fall T, van Dam RM, et al. Evidence of a causal relationship between adiponectin levels and insulin sensitivity: A Mendelian randomization study. Diabetes 2013;62:1338-1344.
28. Landsberg L, Aronne LJ, Beilin LJ, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: A position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens (Greenwich) 2013;15:14-33.
29. Reaven GM. Insulin resistance: The link between obesity and cardiovascular disease. Med Clin North Am 2011;95:875-892.
30. Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol 2013;218:R25- R36.
31. Racette SB, Evans EM, Weiss EP, Hagberg JM, Holloszy JO. Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50-95 year olds. Diabetes Care 2006;29:673-678.
32. Sierra-Johnson J, Johnson BD, Bailey KR, Turner ST. Relationships between insulin sensitivity and measures of body fat in asymptomatic men and women. Obes Res 2004;12:2070-2077.
33. Thorand B, Baumert J, Döring A, et al.; KORA Group. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006; 184:216-224.
34. Lear SA, Chen MM, Birmingham CL, Frohlich JJ. The relationship between simple anthropometric indices and C-reactive protein: Ethnic and gender differences. Metabolism 2003;52:1542-1546.
35. Rossi IA, Bochud M, Bovet P, et al. Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations. Eur J Epidemiol 2012;27:379-384.
36. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282: 2131-2135.
37. Pascot A, Lemieux S, Lemieux I, et al. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care 1999;22:1471-1478.
38. Darmon P. Intentional weight loss in older adults: useful or wasting disease generating strategy? Curr Opin Clin Nutr Metab Care 2013;16:284- 289.
39. Davey Smith G. Random allocation in observational data: how small but robust effects could facilitate hypothesis-free causal inference. Epidemiology 2011;22:460-463.
40. Burgess S, Thompson SG. Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol 2013;42:1134-1144.
41. Willer CJ, Schmidt EM, Sengupta S, et al.; Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. Nat Genet 2013;45: 1274-1283.